ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0428

Placental Characteristics in Systemic Lupus Erythematosus Pregnancies Resulting in Small for Gestational Age Infants

Rashmi Dhital1, Marni Jacobs2, Chelsey Smith3 and Mana Parast2, 1UC San Diego, Brentwood, TN, 2UC San Diego, San Diego, CA, 3UC San Diego, LA JOLLA, CA

Meeting: ACR Convergence 2024

Keywords: pregnancy, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: About a quarter of pregnant individuals with systemic lupus erythematosus (SLE) have small for gestational age (SGA) infants. We aim to characterize placental pathology associated with SGA infants in SLE.

Methods: We retrospectively analyzed SLE deliveries who underwent placental analysis at UC San Diego from 11/2018-10/2023. We compared clinical and placental characteristics of SLE pregnancies that resulted in SGA to those that did not, and additionally, to a control group of matched pregnancies without SLE that resulted in SGA infants. Fisher’s exact and Mann-Whitney U tests were used to compare categorical and continuous variables, respectively.

Results: Placental analysis was available for 28/70 (40%) SLE deliveries, which had a higher rate of adverse outcomes (75%) compared to 12% in those without placental analysis, and among these 28, all exhibited at least one placental abnormality (Table 1, Table 2). Twelve pregnancies resulted in SGA infants and 16 did not. Key placental findings distinguishing SLE pregnancies with SGA infants (vs. those without SGA) included small placental disc for gestational age (100% vs 56%, p = 0.01), placental disc infarct (50% vs 6%, p = 0.02), and increased perivillous fibrin deposition (PVFD, 58% vs 0%, p=0.001). Notably, 7/28 (25%) of studied SLE deliveries with available placental pathology exhibited increased PVFD, and all seven resulted in SGA infants (Table 2). Additionally, when compared to age- (±5 years) and gravidity- (primigravida vs non-primigravida) matched non-SLE pregnancies with SGA at a ratio of 3:1 (n=36), the only placental lesion that distinguished the two groups was a higher prevalence of increased PVFD in SLE-associated SGA cases (58% versus 22%, p = 0.03). The rate of placental disc infarct was similar in both groups (50%) (Table 3).

Conclusion: All 28 SLE deliveries with available placental pathology exhibited at least one histopathologic abnormality. Key placental features in SLE-associated SGA included small placenta, placental disc infarct, and increased PVFD. The occurrence of increased PVFD in placentas of SLE-associated SGA (58%) at a significantly higher rate compared to both SLE placentas without SGA (0%) as well as non-SLE placentas with SGA (22%) suggests that this lesion may represent a specific mechanism of placental injury leading to SGA in SLE. Increased PVFD has a reported prevalence of 0.09 – 2.7%, with a high recurrence rate (12-80%), and notable association with poor pregnancy outcomes (fetal deaths: 15 to 80 %, preterm births: 16.3-60% intrauterine growth restriction/SGA: 9 to >90%), which may be mitigated with the use of certain therapies. We propose that the presence of this lesion in the placenta, particularly in the setting of SGA, should warrant a closer look for potential underlying maternal autoimmune diseases, such as SLE.

Supporting image 1

Table 1. Clinical characteristics of individuals with SLE with and without small for gestational age (SGA) infants,
(11/2018_10/2023), n=28

Supporting image 2

Table 2. Placental characteristics of individuals with SLE with and without small for gestational age (SGA) infant,
( 11/2018_10/2023), n=28

Supporting image 3

Table 3. Comparison of clinical and placental characteristics between SLE-associated small for gestational age (SGA) infants compared to SGA infants from matched individuals without SLE (11/2018_10/2023)


Disclosures: R. Dhital: None; M. Jacobs: None; C. Smith: None; M. Parast: None.

To cite this abstract in AMA style:

Dhital R, Jacobs M, Smith C, Parast M. Placental Characteristics in Systemic Lupus Erythematosus Pregnancies Resulting in Small for Gestational Age Infants [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/placental-characteristics-in-systemic-lupus-erythematosus-pregnancies-resulting-in-small-for-gestational-age-infants/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/placental-characteristics-in-systemic-lupus-erythematosus-pregnancies-resulting-in-small-for-gestational-age-infants/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology